NLFKF yields 6.06% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, NLFKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NLFKF + JNJ for your $10,000?
Nilfisk Holding A/S develops, manufactures, and sells cleaning solutions and services worldwide. It operates through five segments: Europe, Americas, APAC, Consumer, and Private Label and Other. The company offers commercial vacuum cleaners, such as upright, wet and dry, and dry vacuum cleaners, as well as industrial vacuum cleaners; floor cleaning machines scrubber dryers, sweepers, combination machines, carpet extractors, burnishers, and steam cleaners; mobile, stationary, and petrol/diesel driven pressure washers; and industry, vehicle, floor care, surface, and textile detergents, as well as care and maintenance products, and disinfectants. It also offers accessories, such as brushes, brooms, pads, and blades for floorcare machines, as well as batteries and chargers. The company serves agriculture, automotive, building and construction, contract cleaners, education, food and beverage, healthcare, hospitality, iron and metal, manufacturing, offices and public buildings, pharma, retail, and warehousing and logistics. It serves customers through a network of dealers and distributors. The company was founded in 1906 and is headquartered in Brøndby, Denmark.
Full NLFKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.